| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647173 | Multiple Sclerosis and Related Disorders | 2018 | 6 Pages |
Abstract
Our results provide evidence that higher CCL18 plasma levels are associated with more severe inflammatory and neurodegenerative brain MRI outcomes in MS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Nicole Ziliotto, Francesco Bernardi, Dejan Jakimovski, Marcello Baroni, Niels Bergsland, Deepa P. Ramasamy, Bianca Weinstock-Guttman, Paolo Zamboni, Giovanna Marchetti, Robert Zivadinov, Murali Ramanathan,